0001209191-23-052650.txt : 20231011 0001209191-23-052650.hdr.sgml : 20231011 20231011172520 ACCESSION NUMBER: 0001209191-23-052650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231006 FILED AS OF DATE: 20231011 DATE AS OF CHANGE: 20231011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cunningham, Richard Anthony CENTRAL INDEX KEY: 0001624783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231321377 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-06 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001624783 Cunningham, Richard Anthony C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, STE. 107 LAKEWAY TX 78734 1 1 0 0 Chief Executive Officer 0 Stock Option (right to buy) 3.0271 2023-10-06 4 A 0 600000 0.00 A 2033-10-05 Common Stock 600000 600000 D The shares subject to the option will vest and become exercisable as follows: ratably in 16 quarterly installments (37,500 per installment) on the first day of each calendar quarter commencing with January 1, 2024, such that option will be full vested on October 1, 2027. /s/ Daniel George, Attorney-in-Fact 2023-10-11